On the occasion of BIO 2018, Business France give you the opportunity to discuss about the impact of Artificial Intelligence in Healthcare and all the questions it raises. How does it work ? and what is under this word ?

For several years, AI has impacted the healthcare economy, the process of drug development and the management of diseases for patients. This new approach raise many questions in term of ethics and use of patients data to improve and accelerate drug development and public health policies.

France has made Artificial Intelligence a priority to, and we are pride to have this open discussion with our experts :

- Stéphane Verguet, Professor of Global Health at Harvard University, USA

- Dr. Monica Lopez, Executive Director, La Petite Noiseuse Productions, USA

-Erik Thomsen, CTO at Blender Logic, USA

-Daniel Serfaty, CEO & Founder at Aptima, USA

Alexis Normand, Head of business at Withings, a french company developping connected devices will moderate the panel

In case of any question you could have, please contact Alexandre Blanchot at alexandre.blanchot@businessfrance.fr